Baxter
BAX
#1140
Rank
โ‚น1.378 T
Marketcap
โ‚น2,700
Share price
0.82%
Change (1 day)
-8.38%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Revenue for Baxter (BAX)

Revenue in 2024 (TTM): โ‚น1.249 Trillion

According to Baxter's latest financial reports the company's current revenue (TTM ) is โ‚น1.266 Trillion. In 2023 the company made a revenue of โ‚น1.233 Trillion an increase over the revenue in the year 2022 that were of โ‚น1.224 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Baxter from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น1.249 T1.3%
2023 โ‚น1.233 T0.71%
2022 โ‚น1.224 T28.68%
2021 โ‚น951.52 B11.46%
2020 โ‚น853.69 B5.36%
2019 โ‚น810.23 B4.2%
2018 โ‚น777.60 B15.32%
2017 โ‚น674.32 B-2.36%
2016 โ‚น690.62 B4.26%
2015 โ‚น662.42 B-31.16%
2014 โ‚น962.26 B2.51%
2013 โ‚น938.74 B20.83%
2012 โ‚น776.94 B5.72%
2011 โ‚น734.93 B27.71%
2010 โ‚น575.49 B-1.27%
2009 โ‚น582.87 B-1.79%
2008 โ‚น593.50 B34.27%
2007 โ‚น442.01 B-3.83%
2006 โ‚น459.64 B3.71%
2005 โ‚น443.20 B7.62%
2004 โ‚น411.81 B1.46%
2003 โ‚น405.89 B5.34%
2002 โ‚น385.31 B4.21%
2001 โ‚น369.75 B14.88%
2000 โ‚น321.84 B16.04%
1999 โ‚น277.35 B6.06%
1998 โ‚น261.49 B8.4%
1997 โ‚น241.22 B23.39%
1996 โ‚น195.49 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น19.160 T 1,412.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.856 T 46.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.286 T 1.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.674 T 32.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น80.02 B-93.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.577 T 182.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น25.24 B-98.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น889.64 B-29.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.751 T 117.22%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น194.65 B-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA